Bavarian Biotech Report 2011/2012 (7MB) - Bio M

PolyQuant GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Oncology, ELISA / EIA, Analysis, Clinical Diagnostics, Proteomics,Clinical ResearchBased on an innovative platform technology for the absolute multiplexquantitation of proteins, PolyQuant offers cost-effective products and servicesfor proteomics and pharma. The technology allows large-scale acquisitionof protein levels, which can be leveraged in drug discovery and biomarkervalidation. The QconCAT technology is particularly well suited for therapid development of protein assays, which typically takes 12 weeks andless. QconCAT-based reference standards for a wide range of topics, such asdisease states or metabolic pathways, are in the pipeline or can be customdesigned on request. PolyQuant offers a full protein analytical service fromarbitrary samples such as cell extracts or blood serum. Alternatively, proteinquantitation products are offered for the implementation of analytical workflowsat the customer. A convenient license path exists for adaptation ofPolyQuant technologies to large scale customer projects.Contact:Markus FischerSt. Veit-Weg 2D-93051 RegensburgPhone: +49 (0) 941 69818-10Fax: +49 (0) 941 69818-28E-Mail: info@polyquant.comInternet: www.polyquant.comPostnova Analytics GmbHBIOTECH DNA/PROTEIN ANALYTICSKeywords: Devices, Analytical Services, Protein/Polymer/NanoparticleCharacterizationPostnova Analytics provides complete analytical solutions for the characterizationof proteins, biopolymers, macromolecules and nanoparticles (1000 Da –10 12 Da, 10 nm – 100 µm). Postnova’s products are used by all major globalcompanies and institutions in the field of biotechnology, pharma, polymerand environmental research, e.g. DOW, BASF, Roche, MIT, TUM. Postnova’sproduct portfolio includes systems, supplies and services based on it’s proprietarypatented FFF technology for protein-virus, aggregate characterization,polymer-rubber characterization, nanoparticle characterization and preparativemicron particle separation. Postnova has two locations inLandsberg, Germany (headquarters) and Salt Lake City, Utah, USA.Contact:Dr. Thorsten KleinMax-Planck-Str. 14D-86899 Landsberg a. L.Phone: +49 (0) 8191 985 688 0Fax: +49 (0) 8191 985 688 99E-Mail: info@postnova.comInternet: www.postnova.comPPD Germany GmbH & Co. KG –Branch officeCROKeywords: Drug Development, Devices, Clinical Research, Logistics,Monitoring, Medical WritingContact:Dr. Peter OberoslerHansastr. 32PPD is a leading global contract research organization providing drug discovery,development and lifecycle management services. Our clients and part-D-80686 MünchenPhone: +49 (0) 89 57877-0Fax: +49 (0) 89 57877-400ners include pharmaceutical, biotechnology, medical device, academic andE-Mail: genl.info@ppdi.comgovernment organizations. With offices in 44 countries and more thanInternet: www.ppdi.com11,000 professionals worldwide, PPD applies innovative technologies, therapeuticexpertise and a commitment to quality to help clients and partnersaccelerate the delivery of safe and effective therapeutics and maximize thereturns on their R&D investments. For more information, visitwww.ppdi.com 103